Renaissance Capital logo

Akoya Biosciences Priced, Nasdaq: AKYA

Provides spatial biology solutions for discovery and clinical research.

Industry: Health Care

Latest Trade: $3.80 0.00 (0.0%)

First Day Return: +30.3%

Return from IPO: -81.0%

Industry: Health Care

We are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Our mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through our CODEX and Phenoptics platforms, reagents, software and services, we offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum, from discovery through translational and clinical research.
more less
IPO Data
IPO File Date 03/26/2021
Offer Price $20.00
Price Range $18.00 - $20.00
Offer Shares (mm) 6.6
Deal Size ($mm) $132
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 04/15/2021
Offer Price $20.00
Price Range $18.00 - $20.00
Offer Shares (mm) 6.6
Deal Size ($mm) $132
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
J.P. Morgan
Morgan Stanley
more
Company Data
Headquarters Marlborough, MA, United States
Founded 2015
Employees 169
Website www.akoyabio.com

Akoya Biosciences (AKYA) Performance